Dow Jones

38 852,86

-0,55%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
Actavis, Inc. (WPI)
Actavis, Inc. (WPI) Actualités

WPI

Watson (WPI)

Actavis, Inc.

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:WPI

1 2 3 4 5 6 7 8 9 10 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
29/01/2013	17h24	Zacks	MedTech Industry Stock Outlook - Jan 2013 - Industry Outlook	NYSE:WPI	Actavis, Inc.
24/01/2013	15h00	PR Newswire (US)	Watson Pharmaceuticals, Inc. is Now Actavis, Inc.	NYSE:WPI	Actavis, Inc.
23/01/2013	15h29	PR Newswire (US)	Watson Confirms Opana® ER Patent Challenge	NYSE:WPI	Actavis, Inc.
23/01/2013	13h30	PR Newswire (US)	Watson Acquires Uteron Pharma SA	NYSE:WPI	Actavis, Inc.
22/01/2013	17h30	Zacks	Canada Approves Forest's Bystolic - Analyst Blog	NYSE:WPI	Actavis, Inc.
18/01/2013	14h00	PR Newswire (US)	Today's Research on Mylan and Watson Pharmaceuticals: One Drug Maker's Sorrow is Another One's Joy	NYSE:WPI	Actavis, Inc.
15/01/2013	00h41	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NYSE:WPI	Actavis, Inc.
15/01/2013	00h41	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NYSE:WPI	Actavis, Inc.
11/01/2013	15h15	PR Newswire (US)	Watson To Host 2013 Investor Meeting January 25 In New York	NYSE:WPI	Actavis, Inc.
09/01/2013	18h00	Zacks	Forest Settles with Glenmark - Analyst Blog	NYSE:WPI	Actavis, Inc.
08/01/2013	22h32	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:WPI	Actavis, Inc.
08/01/2013	22h32	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:WPI	Actavis, Inc.
08/01/2013	10h36	Zacks	Stock Market News for January 8, 2013 - Market News	NYSE:WPI	Actavis, Inc.
07/01/2013	15h52	Zacks	Impax Launches Opana ER Generic - Analyst Blog	NYSE:WPI	Actavis, Inc.
07/01/2013	12h00	Zacks	Watson's Generic Product Approved - Analyst Blog	NYSE:WPI	Actavis, Inc.
04/01/2013	19h21	Zacks	Tough Times Ahead for Endo Health - Analyst Blog	NYSE:WPI	Actavis, Inc.
04/01/2013	19h17	Zacks	Patent Challenge for Auxilium Pharma - Analyst Blog	NYSE:WPI	Actavis, Inc.
03/01/2013	15h00	PR Newswire (US)	Watson's Generic Lysteda® Receives FDA Approval	NYSE:WPI	Actavis, Inc.
02/01/2013	11h00	Zacks	Watson Files Velcade ANDA - Analyst Blog	NYSE:WPI	Actavis, Inc.
28/12/2012	15h00	PR Newswire (US)	Watson Confirms Velcade® Patent Challenge	NYSE:WPI	Actavis, Inc.
28/12/2012	14h33	PR Newswire (US)	EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals	NYSE:WPI	Actavis, Inc.
26/12/2012	15h28	Marketwired	LYB, WPI, SSYS and HW Freshly Hit a New 52-Week High	NYSE:WPI	Actavis, Inc.
21/12/2012	15h15	PR Newswire (US)	Watson to Present at the 31st Annual J.P. Morgan Healthcare Conference	NYSE:WPI	Actavis, Inc.
20/12/2012	15h15	PR Newswire (US)	Watson to Present at 2013 Goldman Sachs Healthcare CEOs Unscripted: A View from the Top	NYSE:WPI	Actavis, Inc.
14/12/2012	14h14	Zacks	An End to Drug Patent Woes? - Analyst Blog	NYSE:WPI	Actavis, Inc.
14/12/2012	09h20	Zacks	Endo Cuts EPS View, CEO to Retire - Analyst Blog	NYSE:WPI	Actavis, Inc.
06/12/2012	14h34	Zacks	Pharma & Biotech Stock Outlook - Dec 2012 - Industry Outlook	NYSE:WPI	Actavis, Inc.
06/12/2012	01h00	Zacks	Pharma & Biotech Stock Outlook - Dec 2012 - Zacks Analyst Interviews	NYSE:WPI	Actavis, Inc.
04/12/2012	12h20	Zacks	Teva's Guidance Lags Expectations - Analyst Blog	NYSE:WPI	Actavis, Inc.
23/11/2012	09h50	Zacks	Another Generic from Dr. Reddy's - Analyst Blog	NYSE:WPI	Actavis, Inc.